GlucoAI Health

AI-driven diabetes management with predictive analytics, adaptive dosing, and personalized coaching for proactive care.

pirbakhsh • 4 March 2025

GlucoAI Technologies S.r.l. is an AI-driven healthcare startup revolutionizing diabetes management. It offers predictive glucose analytics, adaptive insulin dosing, and AI-powered coaching. With academic backing, regulatory compliance, and strategic partnerships, …

Problem

Current diabetes management tools lack real-time AI-driven glucose forecasting.
Patients struggle with insulin dose optimization and lifestyle adjustments.
Fragmented communication between patients and healthcare providers.

Solution

GlucoAI offers:

AI-powered predictive glucose monitoring with a 92% accuracy rate.
Adaptive insulin adjustment algorithms reducing hypoglycemia risks.
Personalized AI-driven behavioral coaching for lifestyle management.

Key Metrics

Reduction in hypoglycemic incidents by 40%.
Improvement in HbA1c levels in 70% of patients (clinical trials).
Retention rate for B2C subscriptions and hospital adoption rates.
Insurance reimbursement adoption by major health providers.

Value Proposition

First-of-its-kind AI system integrating glucose forecasting, insulin optimization, and personalized coaching.
Federated learning ensures privacy while training AI models securely.
Interoperable platform that connects with 95% of global CGM and EHR systems.
Clinically validated and backed by top-tier medical institutions.

Unfair Advantage

Patented AI-driven glucose prediction and insulin automation algorithms.
Exclusive partnerships with University of Salerno and top-tier hospitals.
Proprietary datasets for AI model training.
Strong IP portfolio with regulatory compliance approvals.

Channels

Direct sales to hospitals, clinics, and insurance providers.
Online subscription models for patients via web and mobile apps.
Integration with CGM and insulin pump manufacturers.
Digital marketing and diabetes patient advocacy networks.

Customer Segments

Healthcare providers (Hospitals, clinics, telemedicine platforms).
Patients with Type 1 & Type 2 diabetes.
Caregivers managing diabetes for elderly or pediatric patients.
Insurance companies covering AI-powered diabetes management tools.

Cost Structure

AI model development and software engineering.
Clinical trials and regulatory approval costs.
Sales, marketing, and customer support expenses.
Infrastructure costs (cloud computing, federated learning architecture).
Legal fees and compliance management.

Revenue Streams

B2B licensing for hospitals and healthcare institutions.
Subscription-based revenue from patients.
Partnerships with CGM and medical device manufacturers.
Insurance reimbursement contracts.
Ethical data licensing for diabetes research collaborations.

GlucoAI Health

Feedback